LORTYRA Trademark

Trademark Overview


On Monday, November 16, 2015, a trademark application was filed for LORTYRA with the United States Patent and Trademark Office. The USPTO has given the LORTYRA trademark a serial number of 86821490. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2017. This trademark is owned by Pfizer Inc.. The LORTYRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
lortyra

General Information


Serial Number86821490
Word MarkLORTYRA
Filing DateMonday, November 16, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 19, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, January 17, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 16, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 14, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 8, 2016ASSIGNED TO EXAMINER
Thursday, November 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 19, 2015NEW APPLICATION ENTERED IN TRAM